Immune Pharmaceuticals Inc (IMNPQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,889 | -32,661 | -17,157 | -23,550 | -5,760 |
| Depreciation Amortization | 3,305 | 999 | 649 | 373 | 308 |
| Income taxes - deferred | -1,791 | -4,937 | N/A | N/A | N/A |
| Accounts receivable | -839 | -98 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -30 | 1,253 | 1,447 | -3,895 | 302 |
| Other Working Capital | -571 | 1,130 | -639 | -3,778 | 1,751 |
| Other Operating Activity | 6,256 | 22,007 | 1,794 | 16,986 | -469 |
| Operating Cash Flow | $-11,559 | $-12,307 | $-13,906 | $-13,864 | $-3,868 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -28 | -21 | -167 | -23 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -1,598 |
| Other Investing Activity | 59 | -29 | -10 | 140 | 466 |
| Investing Cash Flow | $31 | $-50 | $-177 | $117 | $-1,132 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,462 | N/A | N/A | 123 |
| Debt Issued | 2,894 | 1,000 | 0 | 11,171 | N/A |
| Debt Repayment | -5,325 | -1,325 | -3,191 | -1,486 | -37 |
| Common Stock Issued | 5,383 | 7,733 | 143 | 11,280 | 4,368 |
| Dividend Paid | -16 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 15,097 | -785 | 14,907 | -500 | 500 |
| Financing Cash Flow | $18,033 | $8,085 | $11,859 | $20,465 | $4,954 |
| Beginning Cash Position | 271 | 4,543 | 6,767 | 49 | 95 |
| End Cash Position | 6,776 | 271 | 4,543 | 6,767 | 49 |
| Net Cash Flow | $6,505 | $-4,272 | $-2,224 | $6,718 | $-46 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,559 | -12,307 | -13,906 | -13,864 | -3,868 |
| Capital Expenditure | -28 | -21 | -167 | -23 | 0 |
| Free Cash Flow | -11,587 | -12,328 | -14,073 | -13,887 | -3,868 |